Commitments and Contingencies - Additional Information (Detail) - USD ($) |
Mar. 02, 2021 |
Feb. 25, 2021 |
Mar. 31, 2021 |
|---|---|---|---|
| Loss Contingencies [Line Items] | |||
| Underwriting discount paid per unit | $ 0.20 | ||
| Underwriting expense paid | $ 5,500,000 | ||
| Deferred Under Writing Commission Per Unit | $ 0.35 | ||
| Deferred underwriting commissions | $ 9,600,000 | $ 9,625,000 | |
| IPO [Member] | |||
| Loss Contingencies [Line Items] | |||
| Overallotment option vesting period | 45 days | ||
| Stock issued during period shares | 3,600,000 | ||
| Deferred underwriting commissions | $ 9,600,000 | ||
| Over-Allotment Option [Member] | |||
| Loss Contingencies [Line Items] | |||
| Overallotment option vesting period | 45 days | ||
| Stock issued during period shares | 3,500,000 |
| X | ||||||||||
- Definition Deferred underwriting commission per unit. No definition available.
|
| X | ||||||||||
- Definition Deferred underwriting commissions noncurrent. No definition available.
|
| X | ||||||||||
- Definition Overallotment option vesting period. No definition available.
|
| X | ||||||||||
- Definition Underwriting discount paid per unit. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|